EGM approves preferential allotment of shares and convertible warrants

Board & Shareholder Meetings View source PDF Explain this filing

NATCAPSUQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.7%Reaction day

₹195.97

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%-2.5% vs market

Pharmaceuticals peers, median of 172sector-0.6%-2.1% vs sector

On the reaction day the stock moved 2.5 pts less than Nifty Microcap 250 and 2.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.7-0.2-2.5-0.6-2.1

Next day

-3.7-0.1-3.6-0.6-3.1

-8.1-3.4-4.8-1.8-6.3

-12.0-3.5-8.5-2.3-9.6

-8.7-2.7-6.1-1.5-7.2

-13.0-1.1-11.9-1.0-12.0

-12.1-0.8-11.2-0.4-11.7

15d

-15.8-2.9-12.9-3.3-12.5

-18.9-3.5-15.5-4.3-14.7

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Natural Capsules held its 1st EGM of 2026 on September 9 via video conferencing. Two special resolutions on preferential allotment were passed with over 99.99% approval. Resolution 1 covers issuance of equity shares on preferential basis (3,090,923 votes in favour out of 3,091,106). Resolution 2 covers issuance of warrants convertible into equity shares on preferential basis (3,090,901 in favour, 205 against). Both resolutions passed with requisite majority as per the scrutinizer's report.

Likely market impact

Preferential allotments will dilute existing shareholders' equity. Watch for follow-up disclosure on issue price and allottees.